FDA approves kallikrein inhibitor to treat hereditary angioedema

被引：27
|
作者：
Thompson, Cheryl A.
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2010年 / 67卷 / 02期
关键词：
D O I：
10.2146/news100005
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [1] FDA Approves Ecallantide (Kalbitor) for Hereditary Angioedema
    不详
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (05) : 573 - 573
  • [2] A review of kallikrein inhibitor lanadelumab in hereditary angioedema
    Hwang, Gloria
    Johri, Ansh
    Ng, Sally
    Craig, Timothy
    [J]. IMMUNOTHERAPY, 2019, 11 (11) : 937 - 944
  • [3] FDA approves patisiran to treat hereditary transthyretin amyloidosis
    Wood H.
    [J]. Nature Reviews Neurology, 2018, 14 (10) : 570 - 570
  • [4] FDA approves new drug to prevent hereditary angioedema attacks
    Lavine, Greg
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (22) : 2080 - 2080
  • [5] Ecallantide - Plasma kallikrein inhibitor, treatment of hereditary angioedema
    Revill, P.
    Mealy, N.
    [J]. DRUGS OF THE FUTURE, 2007, 32 (07) : 590 - 594
  • [6] Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema
    Aygoeren-Puersuen, E.
    Bygum, A.
    Grivcheva-Panovska, V.
    Magerl, M.
    Graff, J.
    Steiner, U. C.
    Fain, O.
    Huissoon, A.
    Kinaciyan, T.
    Farkas, H.
    Lleonart, R.
    Longhurst, H. J.
    Rae, W.
    Triggiani, M.
    Aberer, W.
    Cancian, M.
    Zanichelli, A.
    Smith, W. B.
    Baeza, M. L.
    Du-Thanh, A.
    Gompels, M.
    Gonzalez-Quevedo, T.
    Greve, J.
    Guilarte, M.
    Katelaris, C.
    Dobo, S.
    Cornpropst, M.
    Clemons, D.
    Fang, L.
    Collis, P.
    Sheridan, W.
    Maurer, M.
    Cicardi, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (04): : 352 - 362
  • [7] A review of oral kallikrein inhibitor berotralstat for hereditary angioedema
    Gao, YingYu
    Hwang, Jacqueline
    Hwang, Gloria
    Craig, Timothy
    [J]. DRUGS OF TODAY, 2022, 58 (02) : 59 - +
  • [8] US FDA approves ATryn® to treat hereditary antithrombin deficiency
    不详
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (02) : 118 - 118
  • [9] The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema
    Levy, Jerrold H.
    O'Donnell, Penrose S.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (09) : 1077 - 1090
  • [10] Kallikrein Inhibition for Hereditary Angioedema
    Longhurst, Hilary J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (08): : 788 - 789
12345